Navigation Links
The conception of Anya, a period-free contraceptive pill

A contraceptive pill intended for consumption without a break is threatening to compete with the conventional oral contraceptive pill//. The pill, named Anya, manufactured by Wyeth Pharmaceuticals, is awaiting approval by health Canada, which will enable women to give a merry slip to the monthly period! Currently unavailable in neither United States nor Canada, Anya is undergoing a testing period marked by extensive clinical trials.

This pill is the first of its kind that is required to be taken daily without a lapse. Christine Derzko, an obstetrician and gynecologist from St. Michael's Hospital in Toronto, who is a keen supporter of the technique in the pill, expressed the extent of relief it would bring to women, who suffer acute menstruation discomfort.

A two-year study on Anya conducted on 79 women revealed that nearly 80% of the 79 women confirmed cessation in the bleeding. About 5 percent reported slight bleeding and spotting. According to researchers, Anya encompasses the same measure of risks like that of a traditional oral contraceptive.

This too is not without criticism, a body that does not support the unnatural cessation of menstrual cycle, say the study has not completely gauged the permanent health implications of using a period-free contraceptive. The lurking fear of breast cancer, or lowered bone density for women on the pill on long durations, is still very much on top of mind. The long term side effects need to be studied extensively before the pill can be considered absolutely safe.


'"/>




Page: 1

Related medicine news :

1. Acupuncture for conception
2. Will anxiety regarding fertility treatment affect the chances of conception?
3. Autism: Symposium to Discuss Myths and Misconceptions
4. Misconceptions Put AIDS Patients In Tight-Spot
5. Misconception on Treatment Options among Prostate Cancer Patients
6. Misconceptions About Eating Eggs Busted
7. Misconceptions About Pet Owners Health Condition Revealed
8. Rajasthan Launches Programs to Overcome Misconceptions About Childbirth
9. Another injectable contraceptive Pill approved by FDA
10. Male contraceptive in trial
11. Hormone contraceptives lead to bone problems
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... , ... January 21, 2017 , ... Seamild, the largest ... the futuristic vision of its owner and founder. As Oat is recognized globally as ... everybody he knows personally as he believes it is a move to sow the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... of Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual ... alumni, family, friends, and community. “Coming Home 2017” will be held on ...
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa Orthopaedics (SRO) ... located at 167 Lynch Creek Way. The Petaluma office features three comfortable patient ... and rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons Dr. ...
(Date:1/21/2017)... ... 2017 , ... The Nobel Biocare™ dental implant company is ... its creos™ line of bone regenerative products. Specifically, the Nobel Biocare™ ... creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In addition ...
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Research and Markets has announced the addition of ... BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, ... 2024" report to their offering. ... The global clinical laboratory testing market is ... of innovative solutions on the grounds of maximum efficiency and minimum ...
(Date:1/20/2017)... BUFFALO, N.Y. , Jan. 20, 2017 /PRNewswire/ ... health programs, has announced the launch of an ... to new guidelines on opioids and helps stem ... Opioids are often prescribed to treat chronic non-cancer ... disease) despite serious risks and lack of evidence ...
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 /PRNewswire/ ... reach USD 233.7 billion by 2025, according to ... The market is anticipated to be predominantly driven ... companies, resulting into the large-scale production of new ... widen the influx of drugs at an unprecedented ...
Breaking Medicine Technology: